
January 10, 2027 (InterContinental San Francisco) — We’re pleased to announce that Diyong Xu, Partner at OrbiMed, will speak at The 8th ACCESS ASIA BD Forum @ JPM 2027.
Hosted by YAFO, ACCESS ASIA builds on the success of ACCESS CHINA, expanding the platform’s reach to foster cross-border connections between Asian biotech innovators and global pharmaceutical companies, investors, and strategic partners. Taking place on January 10, 2027, at the InterContinental San Francisco, the forum will provide a global platform for Asian biotech companies to showcase their innovations, connect with potential partners, and identify new business development and collaboration opportunities. View more information at: https://biotochina.org/
About the Speaker
Diyong Xu is a Partner at OrbiMed in New York, where he focuses on venture capital investments in biotech, medtech, and diagnostics companies. Prior to joining OrbiMed, Diyong worked as an investment banker in the healthcare group at Lazard, concentrating on M&A, financings, and strategic advisory projects.
Diyong holds an M.S. in Management Science and Engineering from Stanford University and an M.S. in Molecular and Cellular Biology from Dartmouth College. He earned his B.S. in Biology from Zhejiang University in China.
About The 8th ACCESS ASIA BD Forum @ JPM 2027
The 8th ACCESS ASIA BD Forum @ JPM 2027 is scheduled to be held on January 10, 2027, at the InterContinental San Francisco.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Date: January 10, 2027 (Sunday)
Venue: InterContinental San Francisco
View more information at: https://biotochina.org/

MORE INFORMATION
Contact Us
To register as an attendee for The 8th ACCESS ASIA BD Forum @ JPM 2027, please visit:
https://jsj.top/f/AqkB9m?x_field_1=Speaker+Promotion
For more information, please contact:
Wendi Xiang